Pasar al contenido principal

Identifican un nuevo mecanismo que contribuye a desarrollar cáncer de colon

IRB Barcelona en los medios
16 Jul 18

Images

Participantes

Contact

Imagen
Communication Officer
Tel.+34 93 40 37255

La Razón, Al Día, Cope, Medical News Today y Medical Xpress, entre otros medios nacionales e internacionales, han publicado un artículo sobre la investigación liderada por Angel R. Nebreda, jefe del laboratorio de Señalización y Ciclo Celular del IRB Barcelona, que ha identificado un nuevo mecanismo que contribuye a desarrollar el cáncer de colon asociado a inflamación y que apunta a nuevos enfoques terapéuticos.

Enlace a Al Día

Enlace a Cope

Enlace a Medical News Today

Enlace a Medical Xpress

Adjunto:

About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 28 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).